COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,871 Articles (22,568 medRxiv, 8,303 bioRxiv)

Most recent first Previous |  Page 791: Articles 7901-7910  | Next

Should I stay or should I go? Observation post-vaccination during the COVID-19 pandemic and the law of unintended consequences
Ingham, G., Kippen, R.
10.1101/2022.04.05.22273373 — Posted: 2022-04-12
The relation between COVID-19 vaccinations and public governance to improve preparedness of next pandemic impacts and crisis management: a global study
Coccia, M., Benati, I.
10.1101/2022.04.10.22273663 — Posted: 2022-04-12
COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review.
Ismail, N., Tavoschi, L., Moazen, B., Rosello, A., Plugge, E.
10.1101/2022.04.07.22273414 — Posted: 2022-04-12
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial
Fong, Y., McDermott, A. B., Benkeser, D., Roels, S., Stieh, D. J., Vandebosch, A., Le Gars, M., Van Roey, G. A., Houchens, C. R., Martins, K., Jayashankar, L., Castellino, F., Amoa-Awua, O., Basappa, M., Flach, B., Lin, B. C., Moore, C., Naisan, M., Naqvi, M., Narpala, S., O'Connell, S., Mueller, A., Serebryannyy, L., Castro, M., Wang, J., Petropoulos, C. J., Luedtke, A., Hyrien, O., Lu, Y., Yu, C., Borate, B., van der Laan, L. W. P., Hejazi, N. S., Kenny, A., Carone, M., Wolfe, D. N., Sadoff, J., Gray, G. E., Grinsztejn, B., Goepfert, P. A., Little, S. J., Paiva de Sousa, L., Maboa, R., Randhawa, A. K., Andrasik, M. P., Hendriks, J., Truyers, C., Struyf, F., Schuitemaker, H., Douoguih, M., Kublin, J. G., Corey, L., Neuzil, K. M., Carpp, L. N., Follmann, D., Gilbert, P. B., Koup, R. A., Donis, R. O., Immune Assays Team, , Janssen Team, , Coronavirus Prevention Network (CoVPN)/ENSEMBLE Team, , United States Government (USG)/CoVPN Biostatistics Team
10.1101/2022.04.06.22272763 — Posted: 2022-04-12
Economic vulnerability and poor service delivery made it more difficult for shack-dwellers to comply with COVID-19 restrictions: The impracticability and inequitable burden of universal/unstratified public health policies.
Ellison, G. T., Mattes, R. B., Rhoma, H., De Wet, T.
10.1101/2022.04.07.22273499 — Posted: 2022-04-12
Model evolution in SARS-CoV-2 spike protein sequences using a generative neural network
Kumar, A.
10.1101/2022.04.12.487999 — Posted: 2022-04-12
Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis
Yogev, O., Weissbrod, O., Battistoni, G., Bressan, D., Naamti, A., Falciatori, I., Berkyurek, A. C., Rasnic, R., Hosmillo, M., Ilan, S., Grossman, I., McCormick, L., Honeycutt, C. C., Johnston, T., Gagne, M., Douek, D. C., Goodfellow, I., Hannon, G. J., Erlich, Y.
10.1101/2022.04.12.488010 — Posted: 2022-04-12
Discrimination of SARS-CoV-2 Omicron sub-lineages BA.1 and BA.2 using a high-resolution melting-based assay: A pilot study
Aoki, A., Adachi, H., Mori, Y., Ito, M., Sato, K., Okuda, K., Sakakibara, T., Okamoto, Y., Jinno, H.
10.1101/2022.04.11.487970 — Posted: 2022-04-12
The SARS-CoV-2 receptor-binding domain facilitates neutrophil transepithelial migration and nanoparticle uptake in the mice airways
Bolkhovitina, E. L., Vavilova, J. D., Bogorodskiy, A. O., Zagryadskaya, Y. A., Okhrimenko, I. S., Sapozhnikov, A. M., Borshchevskiy, V. I., Shevchenko, M. A.
10.1101/2022.04.12.488042 — Posted: 2022-04-12
Broadly neutralizing antibodies target the coronavirus fusion peptide
Dacon, C., Tucker, C., Peng, L., Lee, C.-C. D., Lin, T.-H., Yuan, M., Cong, Y., Wang, L., Purser, L., Williams, J. K., Pyo, C.-W., Kosik, I., Hu, Z., Zhao, M., Mohan, D., Cooper, A., Peterson, M., Skinner, J., Dixit, S., Kollins, E., Huzella, L., Perry, D., Byrum, R., Lembirik, S., Zhang, Y., Yang, E. S., Chen, M., Leung, K., Weinberg, R. S., Pegu, A., Geraghty, D., Davidson, E., Douagi, I., Moir, S., Yewdell, J. W., Schmaljohn, C., Crompton, P. D., Holbrook, M. R., Nemazee, D., Mascola, J. R., Wilson, I. A., Tan, J.
10.1101/2022.04.11.487879 — Posted: 2022-04-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).